Loading…
Loading…
EQUITY / NASDAQ · XNCM
HeartSciences Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →05/01/2026 – 07/31/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗4.35 USD · 1.1628%
Observed: Oct 2, 2026, 11:53 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 4.3 USD · Volume 178,161
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
05/01/2026 – 07/31/2026 · Units
| Metric | 2027 / Quarter 1 | Prior year | Change |
|---|---|---|---|
| Revenue | 2,100 USD | — | — |
| Operating profit | -2,939,090 USD | — | — |
| Net income | -3,172,344 USD | — | — |
| Operating cash flow | -1,318,859 USD | — | — |
| Cash and cash equivalents | 29,906 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2027 / Quarter 105/01/2026 – 07/31/2026ConsolidatedUnits · USD | 2027 / Year end06/30/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 104/30/2026 – 04/30/2026ConsolidatedUnits · USD | 2026 / Year end05/01/2025 – 04/30/2026ConsolidatedUnits · USD | 2026 / Quarter 311/01/2025 – 01/31/2026ConsolidatedUnits · USD | 2026 / Quarter 305/01/2025 – 01/31/2026ConsolidatedUnits · USD | 2026 / Year end12/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2026 / Quarter 310/31/2025 – 10/31/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 29,906 USD | 1,656,814 USD | 1,656,814 USD | 1,700,000 USD | 3,397,035 USD | — | 1,098,098 USD | — |
| Financing cash flowCash flow statement | -27,942 USD | — | — | 8,029,875 USD | — | 8,093,548 USD | — | — |
| Gross profitIncome statement | 1,340 USD | — | — | 2,551 USD | 0 USD | 2,551 USD | — | — |
| Investing cash flowCash flow statement | -280,107 USD | — | — | -44,452 USD | — | -44,452 USD | — | — |
| Net incomeIncome statement | -3,172,344 USD | — | — | -9,141,875 USD | -1,985,208 USD | -6,390,971 USD | — | — |
| Operating cash flowCash flow statement | -1,318,859 USD | — | — | -7,426,707 USD | — | -5,750,159 USD | — | — |
| Operating profitIncome statement | -2,939,090 USD | — | — | -8,412,867 USD | -1,928,940 USD | -5,876,462 USD | — | — |
| RevenueIncome statement | 2,100 USD | — | — | 4,319 USD | 0 USD | 4,319 USD | — | — |
| Total assetsBalance sheet | 3,737,092 USD | 5,262,673 USD | 5,262,673 USD | — | 7,554,503 USD | — | 4,222,909 USD | — |
| Total equityBalance sheet | -2,033,145 USD | 226,060 USD | 226,060 USD | 226,060 USD | 2,652,123 USD | — | 205,171 USD | 4,182,470 USD |
| Total liabilitiesBalance sheet | 5,770,237 USD | 5,036,613 USD | 5,036,613 USD | — | 4,902,380 USD | — | 4,017,738 USD | — |
| Capital expendituresCash flow statement | — | — | — | 3,554 USD | — | 3,554 USD | — | — |
| Report source | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 03/16/2026 | Open report ↗ Published: 03/16/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 03/16/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.